跳至主要内容
临床试验/NCT06124300
NCT06124300已完成不适用

A Single Group Study to Evaluate the Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome

Rael2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年8月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Changes in menstrual cycle regularity.

研究概览

简要总结

This is a virtual single group study that will last 12 weeks. Participants will take 1 scoop of the female hormone balance supplement, and mix it with their drink of choice every morning. Questionnaires will be completed at baseline, 1 week, 2 weeks, 4 weeks, and 12 weeks

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged between 18 - 55
  • BMI less than 35
  • Self-reported concerns around irregular menstrual cycles and ovulation, mood swings, stress, irritability, and low energy
  • Generally healthy - don't live with any uncontrolled chronic disease
  • Self-reported symptoms of PCOS - irregular periods
  • Self-reported concerns with hormonal skin issues

排除标准

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone with known severe allergic reactions
  • Anyone who is pregnant, breastfeeding, or attempting to become pregnant
  • Unwilling to follow the study protocol

结局指标

主要结局

Changes in menstrual cycle regularity.

时间窗: Baseline to Week 12

Study-specific questionnaires completed by participants. Questionnaires utilize a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., "Very regular") and 1 representing the least favorable/worst outcome (e.g., "Extremely irregular").

Changes in hormonal acne.

时间窗: Baseline to Week 12

Study-specific questionnaires completed by participants. Questionnaires utilize a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").

Changes in skin issues throughout the menstrual cycle.

时间窗: Baseline to Week 12

Study-specific questionnaires completed by participants. Questionnaires utilize a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").

次要结局

  • Changes in overall mood.(Baseline to Week 12)
  • Changes in energy.(Baseline to Week 12)
  • Changes in stress levels.(Baseline to Week 12)
  • Changes in food cravings.(Baseline to Week 12)
  • Changes in menstrual cramps.(Baseline to Week 12)

研究者

发起方
Rael
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验